This inventor holds 7 USPTO granted patents and 4 published patent applications and 2 EPO patents. Top assignees: Celestra Life Science LLC, Teclison Limited, Virginia Commonwealth University. Active years: 2017-2025.
Company Filing History:



Years Active: 2017-2025
Title: Ruey-Min Lee: Innovator in Cancer Therapy
Introduction
Ruey-Min Lee is a prominent inventor based in Short Hills, NJ (US). She has made significant contributions to the field of cancer therapy, holding a total of 7 patents. Her innovative approaches focus on enhancing immune responses to solid tumors, showcasing her dedication to advancing medical science.
Latest Patents
Among her latest patents, Ruey-Min Lee has developed compositions and methods for immune-mediated cancer therapy. These methods involve administering a hypoxia-activated bioreductive agent (HABA) to enhance the immune response to solid tumors. The process includes inducing hypoxia and administering an immune checkpoint inhibitor to improve the immune response compared to scenarios without the inhibitor. Additionally, she has created a method for determining the efficacy of GPC3-targeting drug therapy in cancer patients. This method assesses the number of immunocytes or the expression levels of specific molecules in biological samples to guide treatment decisions.
Career Highlights
Ruey-Min Lee has worked with notable companies such as Celestra Life Science LLC and Teclison Limited. Her experience in these organizations has allowed her to collaborate with other experts in the field and contribute to groundbreaking research in cancer therapies.
Collaborations
Ruey-Min Lee has collaborated with colleagues such as Allen J Lee and Jason J Lee. These partnerships have further enriched her research and development efforts in the medical field.
Conclusion
Ruey-Min Lee's innovative work in cancer therapy exemplifies her commitment to improving patient outcomes through scientific advancements. Her patents and collaborations highlight her role as a leading inventor in the medical research community.